Bliss GVS Pharma Limited — Others, 12-05-2025: Change in Auditors

Bliss GVS Pharma has announced a board meeting to approve the financial results for the quarter and year. The auditors issued an unmodified opinion. The Board proposed a final dividend of 0.50 paisa per share, subject to shareholder approval. BDO India LLP was re-appointed as Internal Auditor for FY 2025-26, and AVS & Associates appointed as Secretarial Auditor for five years, pending approval. Bliss GVS International Pte. Ltd. sold its 51% stake in Greenlife Bliss Healthcare Ltd (Nigeria) for USD 1.3 million, ending its step-down subsidiary status. Up to 12.1 lakh sweat equity shares will be issued to key executives recognizing their contributions.